[Evaluation of therapeutic results in thyroid cancer].
D000328:Adult; D000367:Age Factors; D000368:Aged; D002277:Carcinoma / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D007456:Iodine Isotopes / Q000627:therapeutic use; D008017:Life Expectancy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D014284:Triiodothyronine / Q000627:therapeutic use
D007456:Iodine Isotopes; D014284:Triiodothyronine
Zur Frage der Beurteilung des Behandlungserfolges beim Schilddrüsenkarzinom.